Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma
- Conditions
- Mesothelioma
- Interventions
- Behavioral: Questionnaires & online virtual support group
- First Posted Date
- 2011-05-19
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 107
- Registration Number
- NCT01356251
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
A Single Center Randomized Controlled Trial Assessing Pain and Quality of Life Following Surgery
- Conditions
- Head and Neck Cancer
- Interventions
- Other: electrocautery resection and quality of life formsOther: Flexible Fiber-based CO2 Laser, Quality of Life forms
- First Posted Date
- 2011-05-18
- Last Posted Date
- 2021-01-15
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 68
- Registration Number
- NCT01355926
- Locations
- 🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸Memoral Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- Other: Prostate Biopsy, Focal Brachytherapy , Assessment of QOL
- First Posted Date
- 2011-05-17
- Last Posted Date
- 2018-10-19
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 3
- Registration Number
- NCT01354951
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸North Shore LIJ, New Hyde Park, New York, United States
🇺🇸Md Anderson Cancer Center, Houston, Texas, United States
Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma
- First Posted Date
- 2011-05-11
- Last Posted Date
- 2017-04-13
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 44
- Registration Number
- NCT01351623
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Immunization With a Pentavalent Vaccine Composed of KLH-conjugates of GD2L, GD3L, Globo H, Fucosyl GM1, and N-Propionylated Polysialic Acid
- Conditions
- Lung Cancer
- Interventions
- Biological: vaccine comprised of KLH conjugates of GD2L, GD3L, Globo H, fucosyl GM1, and N-propionylated polysialic acid plus OPT-821 adjuvant
- First Posted Date
- 2011-05-06
- Last Posted Date
- 2016-01-05
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 21
- Registration Number
- NCT01349647
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer
- First Posted Date
- 2011-04-29
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 69
- Registration Number
- NCT01345175
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center Commack, Commack, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center at Basking Ridge, Basking Ridge, New Jersey, United States
Telemedicine Evaluation for Stem Cell Transplant Patients
- Conditions
- Stem Cell Transplant Patients
- Interventions
- Behavioral: virtual medical visit
- First Posted Date
- 2011-03-29
- Last Posted Date
- 2020-08-14
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 43
- Registration Number
- NCT01324427
- Locations
- 🇺🇸
Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center, Sleepy Hollow, New York, United States
Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity
- Conditions
- Melanoma
- Interventions
- Drug: Ipilimumab, Melphalan and Dactinomycin
- First Posted Date
- 2011-03-25
- Last Posted Date
- 2018-05-15
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 26
- Registration Number
- NCT01323517
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Trial of Individual Psychosocial Interventions for Cancer Patients
- Conditions
- Advanced Solid Tumor Diseases
- Interventions
- Behavioral: standard Individual Supportive Psychotherapy (ISP)Behavioral: Individual Meaning-Centered Psychotherapy (IMCP)Behavioral: enhanced usual care (EUC)
- First Posted Date
- 2011-03-25
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 346
- Registration Number
- NCT01323309
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Drug: Randomization to No Panitumumab
- First Posted Date
- 2011-03-11
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 75
- Registration Number
- NCT01312857
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸Memorial Sloan Kettering Westchester, Harrison, New York, United States